| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.51 | 2e-14 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.51 | 3e-14 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-08 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-06 |